242 related articles for article (PubMed ID: 30014520)
1. A Transforming Growth Factor-β and H19 Signaling Axis in Tumor-Initiating Hepatocytes That Regulates Hepatic Carcinogenesis.
Zhang J; Han C; Ungerleider N; Chen W; Song K; Wang Y; Kwon H; Ma W; Wu T
Hepatology; 2019 Apr; 69(4):1549-1563. PubMed ID: 30014520
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
[TBL] [Abstract][Full Text] [Related]
3. H19/miR-148a/USP4 axis facilitates liver fibrosis by enhancing TGF-β signaling in both hepatic stellate cells and hepatocytes.
Zhu J; Luo Z; Pan Y; Zheng W; Li W; Zhang Z; Xiong P; Xu D; Du M; Wang B; Yu J; Zhang J; Liu J
J Cell Physiol; 2019 Jun; 234(6):9698-9710. PubMed ID: 30362572
[TBL] [Abstract][Full Text] [Related]
4. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
[TBL] [Abstract][Full Text] [Related]
5. TGF-β signaling alters the pattern of liver tumorigenesis induced by Pten inactivation.
Morris SM; Carter KT; Baek JY; Koszarek A; Yeh MM; Knoblaugh SE; Grady WM
Oncogene; 2015 Jun; 34(25):3273-82. PubMed ID: 25132272
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy.
Romero-Gallo J; Sozmen EG; Chytil A; Russell WE; Whitehead R; Parks WT; Holdren MS; Her MF; Gautam S; Magnuson M; Moses HL; Grady WM
Oncogene; 2005 Apr; 24(18):3028-41. PubMed ID: 15735717
[TBL] [Abstract][Full Text] [Related]
7. Depletion of Tgfbr2 in hepatocytes alleviates liver fibrosis and restores hepatic function in fibrotic mice.
Liu SQ; Deng X; Zhu CP; Cui YL; Xie WF; Zhang X
J Dig Dis; 2023 Jan; 24(1):39-50. PubMed ID: 36967587
[TBL] [Abstract][Full Text] [Related]
8. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
9. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancer.
Baek JY; Morris SM; Campbell J; Fausto N; Yeh MM; Grady WM
Int J Cancer; 2010 Sep; 127(5):1060-71. PubMed ID: 20020490
[TBL] [Abstract][Full Text] [Related]
11. Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis.
Mamiya T; Yamazaki K; Masugi Y; Mori T; Effendi K; Du W; Hibi T; Tanabe M; Ueda M; Takayama T; Sakamoto M
Lab Invest; 2010 Sep; 90(9):1339-45. PubMed ID: 20531292
[TBL] [Abstract][Full Text] [Related]
12. POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.
Wang B; Xu X; Yang Z; Zhang L; Liu Y; Ma A; Xu G; Tang M; Jing T; Wu L; Liu Y
EBioMedicine; 2019 Mar; 41():320-332. PubMed ID: 30745168
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
[TBL] [Abstract][Full Text] [Related]
14. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
[TBL] [Abstract][Full Text] [Related]
15. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes.
Weng HL; Ciuclan L; Liu Y; Hamzavi J; Godoy P; Gaitantzi H; Kanzler S; Heuchel R; Ueberham U; Gebhardt R; Breitkopf K; Dooley S
Hepatology; 2007 Oct; 46(4):1257-70. PubMed ID: 17657819
[TBL] [Abstract][Full Text] [Related]
16. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular expression of a dominant-negative mutant TGF-beta type II receptor accelerates chemically induced hepatocarcinogenesis.
Kanzler S; Meyer E; Lohse AW; Schirmacher P; Henninger J; Galle PR; Blessing M
Oncogene; 2001 Aug; 20(36):5015-24. PubMed ID: 11526486
[TBL] [Abstract][Full Text] [Related]
18. Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer.
Caballero-Díaz D; Bertran E; Peñuelas-Haro I; Moreno-Càceres J; Malfettone A; López-Luque J; Addante A; Herrera B; Sánchez A; Alay A; Solé X; Serrano T; Ramos E; Fabregat I
J Hepatol; 2020 Jan; 72(1):125-134. PubMed ID: 31562907
[TBL] [Abstract][Full Text] [Related]
19. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice.
Oe S; Lemmer ER; Conner EA; Factor VM; Levéen P; Larsson J; Karlsson S; Thorgeirsson SS
Hepatology; 2004 Nov; 40(5):1098-105. PubMed ID: 15389868
[TBL] [Abstract][Full Text] [Related]
20. H19/TET1 axis promotes TGF-β signaling linked to endothelial-to-mesenchymal transition.
Cao T; Jiang Y; Li D; Sun X; Zhang Y; Qin L; Tellides G; Taylor HS; Huang Y
FASEB J; 2020 Jun; 34(6):8625-8640. PubMed ID: 32374060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
